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Accepted 3 December 2012On 20 September 2012, ProMED-mail posted a report on the
identiﬁcation of a novel coronavirus (nCoV) isolated from sputum
from a fatal case of a severe respiratory illness (SARI) with renal
failure in a 60 year old citizen of Saudi Arabia.1,2
The illness had occurred in June 2012. Three days later (23
September 2012) ProMED-mail posted on a second case of SARI
also associated with renal failure in a 49 year old Qatari citizen in
critical condition in a hospital in the United Kingdom (UK), having
been transferred to the UK for intensive care. The second case had
been tested for the nCoV after the clinicians in the UK read the
ProMED-mail report on the ﬁrst case.3
Comparison of sequencing of the 2 isolates was done revealing
99.5% match with one nucleotide mismatch over the regions
compared.4–6 The nCoV was identiﬁed as a new member of the beta
group of CoVs, closely related to a bat CoV identiﬁed in 2008 in the
Netherlands.7 These two cases were not epidemiologically linked.
Epidemiologic and laboratory investigations of known contacts of
these two cases did not reveal secondary cases. (13 close contact
healthcare workers in the UK gave a history of mild self-limiting
respiratory symptoms 10 of whom were tested for the nCoV and
were found to be negative).8 The conclusion at that time was that
the virus did not exhibit person to person transmission. Both cases
had a history of exposure to animals in the period preceding the
onset of their illnesses.
On 25 September 2012, an astute ProMED-mail subscriber, Dr.
Irene Lai, requested information on a report of an undiagnosed§ ProMED-mail is a program of the (International Society for Infectious Diseases)
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outbreak involved 11 individuals including seven nurses, one
doctor and a brother of one of the nurses, with one death in a nurse
with ‘‘underlying medical conditions’’. On 30 November 2012,
WHO reported that testing of specimens from two of the cases in
this cluster were positive for this nCoV – both of these cases had
fatal outcomes, presumably one was the nurse mentioned in the
reports in April 2012 and the other was the original patient
admitted to the ICU with SARI.10
In response to the ﬁrst two conﬁrmed cases in late September
2012, a case deﬁnition for heightened surveillance was developed
by WHO.11,12 The WHO deﬁnition of a ‘‘Patient under investiga-
tion’’ included ‘‘a person with an acute respiratory infection AND
suspicion of pulmonary parenchymal disease based on clinical or
radiological evidence of consolidation AND travel to or residence in
an area where infection with nCoV has recently been reported or
where transmission could have occurred AND is not already
explained by any other infection or aetiology’’.12
On 4 November 2012, the Ministry of Health (MoH) of the
Kingdom of Saudi Arabia (KSA) issued a press release and report for
ProMED-mail announcing a new case of SARI associated with
infection with the nCoV in a Saudi Arabian citizen, resident of
Riyadh, with a history of visit to a farm one week preceding onset of
his illness – the third conﬁrmed case.13,14
On 21 November 2012 ProMED-mail posted a machine
translation of a Saudi Arabian newswire containing a KSA MoH
press release announcing a fourth case of SARI associated with
infection with the nCoV.15 Epidemiologic ﬁndings associated with
the fourth case was not available at that time.
On 23 November 2012, WHO issued a report on the Global
Outreak Alert and Response (GAR) website detailing an additional
four conﬁrmed cases of SARI associated with infection with the
nCoV. Of these four cases, three involved Saudi Arabian citizens
(including two fatalities) and one Qatari citizen.16 Of note was that
the three newly conﬁrmed cases in the KSA (including the two
fatalities) were epidemiologically linked – family members living
in the same household. An additional family member had similar
symptoms, but his laboratory studies ultimately proved negative
for infection with the nCoV.16,10ses. Published by Elsevier Ltd. All rights reserved.
Table 1
Cases of novel Corona virus infection reported as of 2 Dec 2012
Case number Month of onset Outcome Location of onset Clinical features Notes
1 April 2012 fatal Jordan* Renal failure
2 April 2012 fatal Jordan Unknown Nurse, linked to case 1, suggests H2H
3 June 2012 fatal Saudi Arabia Renal failure First reported case: Animal contact
4 Sept 2012 Qatar** Renal failure UK hosp
5 Nov 2012 Saudi Arabia Transient renal failure Animal contact
6 Nov 2012 fatal Saudi Arabia Renal failure Linked case 8 and case 9
7 Nov 2012 Qatar Unknown Germany hosp
8 Nov 2012 Saudi Arabia No renal failure Linked case 6 and case 9
9 Nov 2012 fatal Saudi Arabia Renal failure Linked (family member) case 8 and case 6
* An additional 9 cases of respiratory illness in this cluster – at present unknown how many had specimens tested for nCoV.
** 13 health care workers with mild respiratory symptoms; 10 tested and were negative for nCoV.
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conﬁrmed cases of SARI associated with infection with the nCoV of
which ﬁve were fatal (a case fatality rate of 56%). Of the nine
conﬁrmed cases, ﬁve were in Saudi Arabian citizens, two in Qatari
citizens and two in Jordanian citizens (Table 1). The nine conﬁrmed
cases involve two identiﬁed clusters – one among family members
sharing the same household in Saudi Arabia and the other
involving healthcare workers in an ICU where a case of SARI
had been treated.
The virus has been identiﬁed by nucleotide sequencing to be a
close genetic relative of a bat coronavirus. Sequencing of a fraction
of the E gene and the ORF 1B gene, ampliﬁed by PCR using
published primers,17 produced identical reads for the ﬁrst Saudi
Arabian case and for the Qatari patient (hospitalised in the UK).
These sequences could be aligned with published sequences of a
human beta coronavirus.18
A phylogenetic analysis of available complete coronavirus
genomes showed that Qatar and Saudi Arabian isolates are closely
related and that these viruses form a distinct clade that is related to
HKU4 and HKU5, two bat coronaviruses isolated from bats in Hong
Kong. Further analyses indicated that their closest relative was
another bat coronavirus isolated in Hong Kong and sequenced in
the Netherlands in 2008.
At present, there are more questions than answers about this
nCoV. In describing an outbreak epidemiologically one usually
begins with a description of ‘‘PPT’’ – person, place and time.
The persons thus far have included predominantly males living
in Eastern Mediterranean countries (Saudi Arabia, Qatar and
Jordan), have included isolated cases and have included family
members and healthcare personnel treating cases.
But, have other SARI clinical cases that have not had etiologies
determined elsewhere in the world been tested for the nCoV?
Is this virus just limited to exposure in these Eastern
Mediterranean countries?
And while the cases in KSA and Qatar have occurred in males,
the outbreak in Jordan involved female nurses. The ﬁrst apparent
outbreak occurred in late April 2012 in Jordan. Is there a travel
history known for the index case in that outbreak?
What are the ‘‘PPT’’ details of the index case? Apparently ﬁve of
the nine conﬁrmed cases had a history of exposure to animals
preceding the onset of illness. What were the animals?
Have there been studies of the animals to see if any of the
animals have/had evidence of infection with this nCoV?
Have there been studies of bats in the areas of possible exposure
of these cases to identify the prevalence of the nCoV infection in
these bats?
As for the current laboratory testing for conﬁrmation of cases
there are questions. During the SARS outbreak in 2003, there werea signiﬁcant proportion of cases that were negative for infection
with the SARS CoV by PCR testing. Does the absence of
conﬁrmation of nCoV infection in healthcare personnel with mild
respiratory symptoms caring for the Qatari national treated in the
UK deﬁnitively rule out the possibility of a milder form of clinical
disease associated with this virus? And the individuals with more
severe illness in Jordan that recovered, were they conﬁrmed as
having had nCoV infection? Some answers may be revealed by the
development of speciﬁc serologic assays for nCoV infection.
It is clearly very early in our body of knowledge on the behavior
of this nCoV. Information on the epidemiology of this organism
including the host/reservoir, the geographic distribution and the
clinical spectrum of disease is presently being identiﬁed – a sample
of nine conﬁrmed cases is too small to feel conﬁdent that we fully
understand this novel virus.
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